Cargando…
Changes in inflammatory and immune drivers in response to immunomodulatory therapies in COVID-19
As the global community strives to discover effective therapies for COVID-19, immunomodulatory strategies have emerged as a leading contender to combat the cytokine storm and improve clinical outcomes in patients with severe disease. Systemic corticosteroids and selective cytokine inhibitory agents...
Autores principales: | Wang, Stephen Y., Chang, C-Hong, Meizlish, Matthew L., Bahel, Parveen, Rinder, Henry M., Lee, Alfred I., Chun, Hyung J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781335/ https://www.ncbi.nlm.nih.gov/pubmed/33398292 http://dx.doi.org/10.1101/2020.12.23.20248547 |
Ejemplares similares
-
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
por: Goshua, George, et al.
Publicado: (2020) -
Circulating Markers of Angiogenesis and Endotheliopathy in COVID-19
por: Meizlish, Matthew L., et al.
Publicado: (2020) -
Circulating markers of angiogenesis and endotheliopathy in
COVID-19
por: Pine, Alexander B., et al.
Publicado: (2020) -
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection.
por: Ma, Lina, et al.
Publicado: (2021) -
Increased complement activation is a distinctive feature of severe SARS-CoV-2 infection
por: Ma, Lina, et al.
Publicado: (2021)